AdaptHealth/$AHCO
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About AdaptHealth
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
- Ticker
- $AHCO
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 10,900
- Headquarters
- Conshohocken, United States
- Website
- adapthealth.com
AdaptHealth Metrics
BasicAdvanced
$814M
-
-$1.68
1.39
-
Price and volume
Market cap
$814M
Beta
1.39
52-week high
$13.43
52-week low
$5.21
Average daily volume
2.4M
Financial strength
Current ratio
1.124
Quick ratio
0.636
Long term debt to equity
1.444
Total debt to equity
1.49
Interest coverage (TTM)
1.56%
Profitability
EBITDA (TTM)
590.569
Gross margin (TTM)
19.18%
Net profit margin (TTM)
-6.79%
Operating margin (TTM)
4.71%
Effective tax rate (TTM)
3.32%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
2.28%
Return on equity (TTM)
-15.22%
Valuation
Price to revenue (TTM)
0.246
Price to book
0.59
Price to tangible book (TTM)
-0.8
Price to free cash flow (TTM)
8.473
Free cash flow yield (TTM)
11.80%
Free cash flow per share (TTM)
0.72
Growth
Revenue change (TTM)
13.47%
Earnings per share change (TTM)
-410.82%
3-year revenue growth (CAGR)
3.04%
3-year earnings per share growth (CAGR)
123.36%
What the Analysts think about AdaptHealth
Analyst ratings (Buy, Hold, Sell) for AdaptHealth stock.
Analyst projections of the future price of AdaptHealth stock.
Bulls say / Bears say
Q2 net revenue rose 12.7% year on year and organic growth was 15.9%, with growth in every reportable segment. Sleep Health and Respiratory Health grew 15.5% and 14.1%, showing that the core business is still gaining volume. (Business Wire)
Selling Diabetes Health to Cardinal Health for $235 million and focusing on sleep, respiratory and supporting home medical equipment should simplify the portfolio and direct capital towards the core. The new e-commerce joint venture also adds home sleep testing and a digital route to the large undiagnosed sleep-apnoea market. (SEC, The Motley Fool)
Management has identifiable recovery levers: a workforce restructuring is expected to deliver $19 million of annualised savings, while refinancing replaced the 6.125% notes due 2028. Management also targets a 20% long-term margin for the West Coast contract if execution improves. (Stock Titan, The Motley Fool)
Profitability is under pressure: second-quarter adjusted EBITDA fell 3.2% and margin dropped to 17.8% from 20.8%. AdaptHealth cut 2026 adjusted EBITDA guidance to $490–520 million from $680–730 million, citing the West Coast contract, a manufacturer price increase and portfolio actions. (Business Wire)
The West Coast capitated contract has missed expectations and is expected to reduce full-year EBITDA by $55 million; capitated revenue is now about 14% of continuing-operations revenue. That makes earnings more sensitive to execution and fixed-cost control, while a moratorium is limiting new fee-for-service Medicare business from the new sites. (StockScreener)
Cash generation has weakened while the balance sheet remains leveraged: first-half free cash flow was negative $48.4 million versus positive $73.3 million a year earlier, and long-term debt was about $1.88 billion at June-end. Continued equipment investment and weaker cash conversion could restrict debt reduction and shareholder returns. (SEC, Stock Titan)
Data summarised monthly by Lightyear AI. Last updated on 27 Sept 2026.
AdaptHealth Financial Performance
Revenues and expenses
AdaptHealth Earnings Performance
Company profitability
Upcoming events
No upcoming events
AdaptHealth News
AllArticlesVideos
Funds containing AdaptHealth
AllUSDEURGBP
Fund name | Fund size | $AHCO weighting |
|---|---|---|
iShares Ageing Population$AGED | $953M | 0.06% |
iShares Ageing Population£AGES | $953M | 0.06% |
iShares Ageing Population€AGED | $903M | 0.06% |
iShares S&P Small Cap 600£ISP6 | $3.2B | 0.04% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.04% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.